Impact of body mass index on incidence of febrile neutropenia and treatment-related mortality in United States veterans with diffuse large B-cell lymphoma receiving rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone

Research output: Contribution to journalLetterpeer-review

16 Scopus citations
Original languageEnglish
Pages (from-to)699-702
Number of pages4
JournalBritish Journal of Haematology
Volume167
Issue number5
DOIs
StatePublished - Dec 1 2014

Keywords

  • Diffuse large B-cell lymphoma
  • Empiric dose-reduction
  • Non-hodgkin lymphoma
  • Obesity
  • Treatment-related toxicity

Cite this